COMMUNIQUÉS West-GlobeNewswire

HempAmericana Enters Booming $71M Smokable Hemp Flower Market with November Branded Product Launch

03/10/2019 - 16:22

NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging company in the CBD products market, is excited to announce the Company’s [...]

Cidara Therapeutics to Present New Clinical and Preclinical Data at Two Upcoming Medical Conferences

03/10/2019 - 16:22

SAN DIEGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will present three [...]

SHP Honors 111 Amedisys Care Centers with SHPBest Awards

03/10/2019 - 16:53

BATON ROUGE, La., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Strategic Healthcare Programs (SHP) recently honored 111 Amedisys, Inc. (NASDAQ:AMED) care centers with SHP Best Awards, recognizing agencies with consistently high- [...]

Tauriga Sciences, Inc. to Showcase its Tauri-Gum Product Line as an Approved Exhibitor at Kosherfest 2019 on November 12th-13th

03/10/2019 - 17:29

Venue: The Meadowlands Exposition Center / Secaucus, New Jersey New York, NY, Oct. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating [...]

SPINEWAY : Compte-rendu de l’Assemblée Générale du 3 octobre 2019

03/10/2019 - 17:45

Compte-rendu de l’Assemblée Générale du 3 octobre 2019 L'Assemblée Générale Ordinaire et Extraordinaire des actionnaires de Spineway s'est réunie ce 3 octobre 2019 à 11h00 au siège social de la société, sur deuxième [...]

Spineway : Report on the October 3, 2019 General Shareholders’ Meeting

03/10/2019 - 17:45

Report on the October 3, 2019 General Shareholders’ Meeting The Spineway Ordinary and Extraordinary Shareholders' Meeting met, on second notice after adjournment, on October 3, 2019 at 11:00 am at the company's [...]

Nombre de droits de vote au 30 septembre 2019

03/10/2019 - 17:45

Nicox SA Société anonyme au capital de 29 914 920 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 3 octobre 2019, PUBLICATION MENSUELLE DU NOMBRE D’ [...]

Number of voting rights as of September 30. 2019

03/10/2019 - 17:45

Nicox SA Société anonyme with a registered capital of € 29,914,920 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On October 3, 2019, MONTHLY PUBLICATION OF THE [...]

Viela Bio Announces Pricing of Initial Public Offering

03/10/2019 - 03:54

GAITHERSBURG, Md., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Viela Bio, Inc., a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced the pricing of its [...]

Aprea Therapeutics Announces Pricing of Initial Public Offering

03/10/2019 - 05:03

BOSTON, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, [...]

Viome Named to the 2019 CB Insights Digital Health 150, List of Most Innovative Digital Health Startups

03/10/2019 - 00:00

Fast-growing healthcare company recognized for achievements in microbiome analysis and chronic disease prevention research SEATTLE, Oct. 02, 2019 (GLOBE NEWSWIRE) -- CB Insights today named Viome to the inaugural [...]

Organovo Acknowledges Receipt of Proposal

03/10/2019 - 01:31

Reiterates Commitment to Strategic Review Process SAN DIEGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO) (“Organovo”) today confirmed that it has received a proposal from Viscient [...]

Cue Biopharma to Present Corporate Overview and Update on Clinical Development Progress for CUE-101 at the Cantor 2019 Global Healthcare Conference

02/10/2019 - 14:00

CAMBRIDGE, Mass., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate [...]

BioCardia Announces the Appointment of Two New Board Members

02/10/2019 - 14:00

SAN CARLOS, Calif., Oct. 02, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the appointment of [...]

Celldex Therapeutics Announces Upcoming Data Presentations

02/10/2019 - 14:01

HAMPTON, N.J., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that multiple Company drug development programs will be the subject of presentations at upcoming medical and [...]

AgraFlora Organics présente les améliorations réalisées sur l'infrastructure du Delta Greenhouse Complex incluant des dépenses en immobilisations corporelles de plus de 30 millions de dollars canadiens

02/10/2019 - 14:03

VANCOUVER, Colombie-Britannique, 02 oct. 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) une société internationale de [...]

REPEAT - AgraFlora Organics Reviews Delta Greenhouse Infrastructure Upgrades; Deploys Over C$30,000,000 in PPE Expenditures

02/10/2019 - 14:03

VANCOUVER, British Columbia, Oct. 02, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]

Dabir Surfaces Inc. Announces Master Product Agreement with Trinity Health

02/10/2019 - 14:26

CHICAGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Dabir Surfaces Inc., a subsidiary of Methode Electronics Inc. (NYSE: MEI), focused on improving patient outcomes through the design and manufacture of an innovative solution [...]

Predictive Oncology Inc. Announces Pricing of Public Offering of Up to $3,167,768.50 of Common Stock

02/10/2019 - 14:27

MINNEAPOLIS, Minn., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive” or “the Company”) today announced the pricing of its previously announced public offering of its common stock, [...]